How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Business Services · Forecast 2027–2033
Blood Card Centrifuge Market
- By Product Type: Benchtop Blood Card Centrifuges, Portable Blood Card Centrifuges, High-Speed Blood Card Centrifuges, Low-Speed Blood Card Centrifuges
- By Application: Clinical Diagnostics, Blood Bank, Research Laboratories, Pharmaceutical Industry, Veterinary Diagnostics
- By End User: Hospitals, Diagnostic Laboratories, Blood Donation Centers, Research Institutes, Pharmaceutical Companies
- By Rotor Type: Fixed-Angle Rotor, Swing-Out Rotor, Vertical Rotor
- By Capacity: Low Capacity (up to 6 blood cards), Medium Capacity (7-12 blood cards), High Capacity (above 12 blood cards)
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Benchtop Blood Card Centrifuges leads By Product Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 15 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 293 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.178 →
- 12 Company Profiles 15 players: SWOT & benchmarking p.186 →
Full report · locked preview
Everything inside the Blood Card Centrifuge Market report
A complete, evidence-based study - 12 chapters and 123 sections covering market size, segmentation across 5 axes, regional analysis and 15 company profiles, forecast to 2033.
Segmentation covered
Product Type 4
Application 5
End User 5
Rotor Type 3
Capacity 3
Companies profiled
Thermo Fisher Scientific
Beckman Coulter (Danaher Corporation)
Eppendorf AG
Hettich Lab Technology
Sigma-Aldrich (Merck Group)
Damon/IEC
Kubota Corporation
Andreas Hettich GmbH & Co. KG
Tomy Digital Biology Co. Ltd.
Hanil Scientific Inc.
LW Scientific
REMI Elektrotechnik Ltd.
+3 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
15 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Thermo Fisher Scientific
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Beckman Coulter (Danaher Corporation)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Eppendorf AG
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Hettich Lab Technology
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Sigma-Aldrich (Merck Group)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Damon/IEC
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Kubota Corporation
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Andreas Hettich GmbH & Co. KG
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Tomy Digital Biology Co. Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Hanil Scientific Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →LW Scientific
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →REMI Elektrotechnik Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →DLAB Scientific Co. Ltd.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →BioSan
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Scilogex
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →
Global · 2025–2033
$1,745M by 2033 · 10.6% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Benchtop Blood Card Centrifuges37.1
- Portable Blood Card Centrifuges19.2
- High-Speed Blood Card Centrifuges22.5
- Low-Speed Blood Card Centrifuges21.3
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$256.9M → $610.2M · 11.4%
Europe$179.1M → $423.0M · 11.3%
Asia Pacific$163.5M → $355.0M · 10.2%
Latin America$101.2M → $232.8M · 11.0%
Middle East and Africa$77.9M → $188.1M · 11.7%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →10.572026
10.582027
10.582028
10.602029
10.612030
10.622031
10.642032
10.652033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Thermo Fisher Scientific18.0
- Beckman Coulter (Danaher Corporation)20.8
- Eppendorf AG5.5
- Hettich Lab Technology10.1
- Sigma-Aldrich (Merck Group)7.2
- Damon/IEC10.4
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Product Type19.4%
Application18.9%
End User13.1%
Rotor Type25.1%
Capacity23.5%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America33.7
- Europe23.4
- Asia Pacific19.6
- Latin America12.9
- Middle East and Africa10.4
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Thermo Fisher Scientific | 91 | 90 | 74 | 74 | 89 | 86 | 84 |
| Beckman Coulter (Danaher Corporation) | 78 | 73 | 77 | 71 | 75 | 93 | 78 |
| Eppendorf AG | 67 | 78 | 76 | 66 | 84 | 74 | 74 |
| Hettich Lab Technology | 76 | 74 | 68 | 63 | 80 | 71 | 72 |
| Sigma-Aldrich (Merck Group) | 58 | 56 | 56 | 71 | 66 | 56 | 61 |
| Damon/IEC | 64 | 58 | 51 | 49 | 59 | 58 | 57 |
| Kubota Corporation | 47 | 47 | 61 | 41 | 56 | 46 | 50 |
| Andreas Hettich GmbH & Co. KG | 42 | 35 | 59 | 48 | 43 | 56 | 47 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Thermo Fisher Scientific
- Beckman Coulter (Danaher Corporation)
- Eppendorf AG
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Thermo Fisher Scientific | ✓ | ✓ | ✓ | − | ◐ | ✓ |
| Beckman Coulter (Danaher Corporation) | ◐ | ◐ | ✓ | ✓ | ◐ | ✓ |
| Eppendorf AG | ✓ | ✓ | ✓ | ◐ | ◐ | − |
| Hettich Lab Technology | ✓ | ◐ | ◐ | − | ◐ | ✓ |
| Sigma-Aldrich (Merck Group) | − | − | ◐ | ◐ | ◐ | ◐ |
| Damon/IEC | − | ◐ | − | − | − | − |
| Kubota Corporation | ◐ | ◐ | − | − | ◐ | − |
| Andreas Hettich GmbH & Co. KG | − | − | ◐ | − | − | ◐ |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Thermo Fisher Scientific84
2Beckman Coulter (Danaher Corporation)78
3Eppendorf AG74
4Hettich Lab Technology72
5Sigma-Aldrich (Merck Group)61
6Damon/IEC57
7Kubota Corporation50
8Andreas Hettich GmbH & Co. KG47
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
Thermo Fisher ScientificBeckman Coulter (Danaher Corporation)
Challenger2
Strong scale, closing on the leaders.
Eppendorf AGHettich Lab Technology
Contender2
Focused players with pockets of strength.
Sigma-Aldrich (Merck Group)Damon/IEC
Niche2
Specialists in a single segment or region.
Kubota CorporationAndreas Hettich GmbH & Co. KG
Go-to-market strategy
Land Product Type in North America, then scale across Blood Card Centrifuge Market — a $614M beachhead inside a $8.46B market.
Beachhead (SOM)$614Mobtainable near-term
Serviceable (SAM)$3.49Breachable market
Primary motionDirect + partner-ledgo-to-market
Time to scale5 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion87 fit
Benchtop Blood Card Centrifuges
Best fit — highest urgency & budget in Product Type.
Economic buyer75 fit
Portable Blood Card Centrifuges
Strong fit — clear ROI and a fast path to value.
End user69 fit
High-Speed Blood Card Centrifuges
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Product Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Application & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + End User
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales45%
Partner / channel29%
Digital / self-serve18%
Marketplaces7%
Positioning & messaging
§GTM 2 · p.194 →For Product Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Blood Card Centrifuge Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified42%
Sales qualified21%
Evaluation13%
Closed-won7%
$17.8KCAC
$105KLTV
5.9:1LTV : CAC
< 4 moCAC payback
Investment thesis
Blood Card Centrifuge Market is a durable-growth opportunity — $818M by 2033, compounding at 6.5%.
TAM · 2025$494Mtoday
TAM · 2033$818Mforecast
CAGR6.5%2027–2033
Cumulative$5.80Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$818MTotal addressable market
SAM$307MServiceable available market
SOM$57MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →6.5% CAGR
Demand compounds through 2033, outpacing GDP across Product Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Product Type moving from early to mainstream — durable secular demand.
Consolidation upside
15+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$818MLarge & growingTAM by 2033 at 6.5% CAGR
$307MServiceable nowreachable with today’s model
$57MBeachhead winobtainable near-term share
15+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$638MBear4.2% CAGR
$818MBase6.5% CAGR
$1.05BBull8.6% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Application optionality
- Customer concentrationBroaden installed base beyond top accounts
Board pack · executive summary
Blood Card Centrifuge Market — a $8.08B market by 2033. Plan: grow share from 8.9% to 18.9%.
Market size · 2033$8.08Btotal addressable
Market CAGR10.8%2027–2033
Target share18.9%from 8.9% today
Revenue ambition$1.53Bby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 8.9% | 18.9% | Behind |
| Revenue | $737M | $1.53B | At risk |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | Behind |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | At risk |
| Gross margin | 33.9% | 43.6% | On track |
| Customer retention | 89.7% | 92.0% | Behind |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Product Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Application capability
A defensible second engine — invest in Application to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Product Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Application
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $163M capacity & capability investment
- Greenlight bolt-on M&A in Application
- Authorise North America expansion plan
- Fund R&D program for Product Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownOn track
- Competitive share lossOn track
- Input-cost & supply riskOn track
- Regulatory / policy changeBehind
- Execution & talentOn track
Sales deck · value proposition
Win the Blood Card Centrifuge Market conversation — a $7.94B market you can size, segment and defend in minutes.
Market size · 2033$7.94Btotal opportunity
Growth6.3%CAGR to 2033
Addressable buyers1,054+accounts in scope
Typical ROI6.2×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Product Type
Goal Grow share in Product Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →6.2×return on cost, year one
< 4 mopayback period
$98K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
15+players profiled in this market
Coverage includes
Thermo Fisher ScientificBeckman Coulter (Danaher Corporation)Eppendorf AGHettich Lab TechnologySigma-Aldrich (Merck Group)Damon/IECKubota CorporationAndreas Hettich GmbH & Co. KG+7 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Blood Card Centrifuge Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Blood Card Centrifuge Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Business Services · scroll →Blood Cell Analysis Market
Market size, share, segmentation and regional forecast.
$2.7B market · 2025 base year
View reportBlood Coagulation Analysis Market
Market size, share, segmentation and regional forecast.
$2.4B market · 2025 base year
View reportBlood Coagulation Factors Market
Market size, share, segmentation and regional forecast.
$2.5B market · 2025 base year
View reportBlood Coagulation Test Analyzer Market
Market size, share, segmentation and regional forecast.
$4.3B market · 2025 base year
View reportBlood Collecting Vehicles Market
Market size, share, segmentation and regional forecast.
$3.1B market · 2025 base year
View reportBlood Collection Devices Market
Market size, share, segmentation and regional forecast.
$2.6B market · 2025 base year
View reportBlood Collection Equipment Market
Market size, share, segmentation and regional forecast.
$3.0B market · 2025 base year
View reportBlood Collection Manager Market
Market size, share, segmentation and regional forecast.
$4.7B market · 2025 base year
View reportBlood Collection Products for Veterinary Use Market
Market size, share, segmentation and regional forecast.
$1.3B market · 2025 base year
View reportBlood Collection System Market
Market size, share, segmentation and regional forecast.
$4.6B market · 2025 base year
View reportBlood Collection Tube for Noninvasive Prenatal Testing (NIPT) Market
Market size, share, segmentation and regional forecast.
$3.0B market · 2025 base year
View reportBlood Collection Tubes (BCT) Market
Market size, share, segmentation and regional forecast.
$5.0B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report ships as a formatted PDF, a fully editable XLSX containing all underlying data tables, and a presentation-ready PPT deck - so you can re-chart, re-model, or drop any figure straight into your own deck.